International Society of Surgery (ISS)

Société Internationale de Chirurgie (SIC)

Integrated Societies: IATSIC | IASMEN | BSI | ISDS

TITLE: CHALLENGES IN MANAGEMENT OF REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE (GERD) IN A RESOURCE LIMITED HOSPITAL SETTING OF A DEVELOPING NATION. afzalanees@gmail.com

 
TITLE: CHALLENGES IN MANAGEMENT OF REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE (GERD) IN A RESOURCE LIMITED HOSPITAL SETTING OF A DEVELOPING NATION.
Author Details
4
Including the presenting author
Afzal Anees afzalanees@gmail.com JNMCH, AMU, Aligarh, India General Surgery Aligarh India *
Meraj Ahmed merajdoc@gmail.com JNMCH, AMU, Aligarh, India General Surgery Aligarh India
Hazique Jameel haziquejameel16@gmail.com JNMCH, AMU, Aligarh, India General Surgery Aligarh India
Shereen Fatima shereenf388@gmail.com JNMCH, AMU, Aligarh, India General Surgery Aligarh India
Afzal Anees
afzalanees@gmail.com
India
Abstract
Oral only
Refractory gastroesophageal reflux disease (GERD) is a significant clinical challenge, defined by persistent GERD symptoms despite optimized proton pump inhibitor therapy. The prevalence of GERD in Indian population ranges from 11% to 20.7% leading to diminished quality of life and substantial burden. While laparoscopic fundoplication (LF) is the established surgical standard , potassium-competitive acid blockers (PCABs) have emerged ; their specific roles in a systematic treatment algorithm require further research.
A prospective series of 73 (P=30% of GERD population, CI=95%, d=0.05) consecutive patients with symptoms of refractory GERD were enrolled; out of 246 patients of GERD (P=20%,CI=95%, d=0.05) over period of 2 years from January 2023 to December 2024. All patients had an objective diagnosis of refractory GERD confirmed by positive impedance-pH monitoring . The study involved an initial 8-week PCAB trial (e.g, fexuprazan). Patients who experienced symptom relief were maintained on PCAB, others were offered LF. Symptom relief was assessed using validated GERD-specific quality of life (GERD-HRQL) questionnaire.
Of the 73 patients, 45% (n=33) achieved significant symptom improvement continuing on PCABs. The remaining 55% (n=40) with persistent symptoms underwent LF. Following LF, 85% (n=34) reported complete resolution and 90% (n=36) were able to discontinue all acid-suppressive medication. The remaining 15% (n=6) reported partial symptom relief requiring intermittent medical management.
This study suggests a structured sequential approach to the management of refractory GERD. This algorithm incorporating PCABs as a bridge between conventional PPI therapy and surgical intervention, provides a clear and effective pathway for managing this challenging subset of population.
 
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
 
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
Category
2 Digestive Surgery organized by ISDS
2.01 Upper Gastro-Intestinal Surgery
Withdrawn
250
Abstract Prizes
No
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript conforming to the format of orignial articles in the World Journal of Surgery WJS by 30 November 2025
Yes
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025
Yes
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025